Geneva, May 4 -- International Clinical Trials Registry received information related to the study (DRKS00039678) titled 'Soft Tissue Sarcoma Registry 2.0-NIS' on April 21.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: Prognosis
Primary Sponsor: Klinikum Stuttgart Olgahospital
Condition:
C49
Malignant neoplasm of other connective and soft tissue
Intervention:
Group 1: Pathologically and molecular proven diagnosis of a soft tissue tumour or sarcoma (centrally reviewed), all ages, available for long term follow up, written informed consent for data collection.
Recruitment Status: Recruiting
Date of First Enrollment: 11/12/2024
Target Sample Size: 3000
Countries of Recru...